Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
30 March 2015 |
Main ID: |
NCT02273622 |
Date of registration:
|
15/10/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects
|
Scientific title:
|
Nutritional Intervention Study to Evaluate the Effect of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects |
Date of first enrolment:
|
October 2014 |
Target sample size:
|
20 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT02273622 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Spain
| | | | | | | |
Contacts
|
Name:
|
Francesco Visioli, Prof |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
IMDEA Food |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Male gender with age range 20-40 years
- Signed patient informed consent
Exclusion Criteria:
- BMI < 19 and >26
- Subjects with a diagnosis of diabetes mellitus, dyslipidemia, hypertension and other
cardiometabolic diseases.
- Subjects with dementia, mental illness or diminished cognitive function.
- Subjects with serious diseases (hepatic, renal, cardiovascular, etc.)
- Subjects who refuse to make the 24 hour urine collection and blood samples under
study.
- Subjects with allergy or intolerance to olive and derivatives.
- Subjects with drug treatment of any kind.
- Current smoking.
Age minimum:
20 Years
Age maximum:
40 Years
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Healthy
|
Intervention(s)
|
Dietary Supplement: placebo
|
Dietary Supplement: hydroxytyrosol
|
Primary Outcome(s)
|
Detoxifying potential of hydroxytyrosol and its effects on Phase II enzyme expression (leading to xenobiotics detoxification in the liver).
[Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
|
Secondary Outcome(s)
|
Number of participants with change in different anthropometrics parameters
[Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
|
Number of participants with change in different biochemical parameters
[Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
|
Concentration of hydroxytyrosol and metabolites in urine
[Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
|
Secondary ID(s)
|
IMD PI011
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|